{
    "text": "Nobiletin (NBT) can sensitize ADR-induced cytotoxicity against A549/ADR cells by inhibiting MRP1 expression, indicating that NBT could serve as an effective adjuvant agent for ADR-based chemotherapy in lung cancer.", 
    "denotations": [
        {
            "id": "T1", 
            "obj": "MRP1", 
            "span": {
                "begin": 92, 
                "end": 96
            }
        }, 
        {
            "id": "T1", 
            "obj": "lung cancer", 
            "span": {
                "begin": 202, 
                "end": 213
            }
        }
    ],
    "relations": [
        {
            "id":"R1",
            "pred":"causes",
            "subj":"T2", 
          "obj":"T1"}
    ]
}